Related Experiment Videos

Concurrent Langerhans cell histiocytosis and nephroblastoma

Ryoko Narui1, Hiroshi Yagasaki, Yoshiyuki Takahashi

  • 1Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Pediatric Blood & Cancer
|January 17, 2009
PubMed

Insights

This report details the first documented case of a child diagnosed with both Langerhans cell histiocytosis (LCH) and nephroblastoma simultaneously. The patient successfully recovered after treatment for both rare pediatric conditions.

Area of Science:

  • Pediatric Oncology
  • Pediatric Pathology
  • Rare Diseases

Background:

  • Langerhans cell histiocytosis (LCH) is a rare clonal proliferative disease of uncertain etiology.
  • Nephroblastoma (Wilms tumor) is the most common renal malignancy of childhood.
  • Concurrent diagnoses of LCH and nephroblastoma are exceptionally rare in pediatric patients.

Observation:

  • A 2-year-old female presented with bone pain and swelling in the right humerus.
  • Incisional biopsy confirmed a diagnosis of Langerhans cell histiocytosis (LCH).
  • Staging work-up revealed an incidental finding of nephroblastoma in the left kidney.

Findings:

  • The patient underwent complete surgical resection of the nephroblastoma.
  • Standard chemoradiotherapy protocols were administered for the nephroblastoma.
  • The patient remains disease-free and without relapse 14 months post-initial presentation.

Implications:

  • This case highlights the importance of comprehensive staging and diagnostic work-up in pediatric patients presenting with rare conditions.
  • It suggests that concurrent LCH and nephroblastoma, while rare, can be managed effectively with current treatment modalities.
  • Further research may explore potential shared etiologies or management strategies for these co-occurring pediatric malignancies.